FDA Approval Conundrum
Why Peptides Aren’t FDA Approved
Why Most Peptides Are Not FDA Approved (And Why That Doesn’t Mean They Don’t Work)
You’ve probably wondered:
“If peptides like BPC-157, TB-500, or GHK-Cu are so effective, why aren’t they FDA approved?”
Here’s the straightforward truth — it’s not because they’re unsafe or don’t work. It’s almost entirely about money and patents.
1. FDA Approval Costs a Fortune
Getting a new drug through full FDA approval costs $500 million to over $2 billion and takes 10–15 years of clinical trials.
Pharmaceutical companies only invest that kind of money if they can make it back — and that requires exclusive patent protection.
2. You Can’t Patent Something the Body Already Makes
Peptides are short chains of amino acids. Many of them (BPC-157, GHK-Cu, Thymosin Beta-4, etc.) are naturally produced by the human body or are identical to fragments that already exist in nature.
Under U.S. patent law (and similar rules worldwide), you cannot patent a naturally occurring substance. If a company can’t get a patent, they have no way to stop competitors from copying the exact same peptide the moment it becomes popular.
Without that monopoly, there is zero financial incentive to spend hundreds of millions on the massive human trials the FDA requires.
3. Big Pharma Focuses on What They Can Patent
That’s why you see FDA-approved drugs that are:
• Completely synthetic new molecules (never before seen in nature)
• Slightly modified versions of natural compounds (so they can be patented)
Natural peptides don’t fit that model. Pharma companies would rather create a brand-new patented drug than invest in something anyone can copy.
4. But the Research Is Still There
Hundreds of independent studies (many from universities and research institutes, not big pharma) have shown impressive results for research peptides in areas like:
• Tissue repair and healing
• Inflammation reduction
• Immune support
• Anti-aging and recovery
These are published in peer-reviewed journals — they’re just not funded by companies that need an FDA stamp to sell them profitably.